Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Scientists Discover Altered 3D Genome Structure in Alzheimer’s Brains

Researchers from Carnegie Mellon University's School of Computer Science, the University of Pittsburgh School of Medicine and the University of Washington shed new light on Alzheimer's disease that could point to new directions for treatment.

24 Jul 2026

Hospital-Trained AI Outperforms GPT-5 At Reading Brain Scans

An AI model trained on hospital brain scans outperforms leading systems in diagnostics and triage, showcasing the potential of clinical data integration.

20 Jul 2026

Lipid Accumulation in Senescent Brain Cells Drives Aging and Alzheimer’s Disease

A new research paper was published in Volume 18 of Aging on July 1, 2026, titled "Senescent cells accumulate lipid droplets."

17 Jul 2026

Researchers Discover Surprising Protective Microglia Roles in Dementia

Researchers at Trinity College Dublin have discovered that microglia – the main immune cells of the brain – play a critical role in maintaining the stability of neuronal networks in Alzheimer's disease.

16 Jul 2026

Arc Protein Identified as Driving Tau Spread in Alzheimer's Disease

Arc's involvement in tau transmission via extracellular vesicles offers new understanding of Alzheimer's disease mechanisms and potential therapeutic pathways.

15 Jul 2026

Research Shows How Alpha Synuclein Interacts With Traditional Alzheimer's Proteins

The aging brain frequently harbors multiple protein pathologies that contribute to Alzheimer's, Parkinson's and other neurodegenerative diseases.

9 Jul 2026

Salk Study Identifies Brain Signaling Target to Prevent Cancer Cachexia

According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle and fat loss, reducing quality of life and sometimes even limiting treatment options.

3 Jul 2026

Researchers Identify Crucial Cell Death in Down Syndrome

Researchers at the Alzheimer's Center at Temple have identified evidence of a new form of cell death known as necroptosis in the brains of individuals with Down Syndrome, with the corresponding biomarkers providing new clues to potential treatment also for Alzheimer's and other neurodegenerative diseases.

1 Jul 2026

Sleep helps neural networks recover adaptive performance after absorbing daily life shocks

Every animal that has ever been studied closely, from the fruit fly to the philosopher, surrenders each day to a state that looks, from the outside, like a small rehearsal for death.

1 Jul 2026

University of Utah Study Identifies Arc Protein as Alzheimer's Driver

Alzheimer's disease is driven by a buildup of a toxic protein called Tau that kills neurons. As toxic Tau spreads to new regions of the brain, symptoms become worse and ultimately fatal.

30 Jun 2026

Salk Institute Decodes Molecular Timeline of Age-Related Neurodegeneration

Neurodegenerative diseases affect tens of millions of people worldwide.

26 Jun 2026

New Karyoptosis Mechanism Linked to Alzheimer's and Frontotemporal Dementia

Markers of a new mechanism for cell death, called karyoptosis, have been found in brains of patients with Alzheimer's disease and frontotemporal dementia (FTD).

26 Jun 2026

Penn Study Uses AI to Discover Prion-Based Antibiotics

New antibiotic candidates for drug-resistant bacteria may reside inside prions, mis-folded protein in the brain best known for rare and fatal degenerative brain diseases.

22 Jun 2026

Collaborative Research Discovers New Treatments for Alzheimer' Disease

A new multimillion-dollar project will bring together researchers from the Indiana University School of Medicine and the IU Luddy School of Informatics, Computing, and Engineering as they work to solve one of medical science's greatest needs: Identifying new treatments for Alzheimer's disease and related dementias.

16 Jun 2026